Theodora Temelkova‐Kurktschiev
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Cardiovascular Health and Disease Prevention, Diabetes Management and Research, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,890 cited
- → Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial(2019)610 cited
- → Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.(2000)545 cited
- → Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial(2020)266 cited
- → Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance(2004)254 cited
- → Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose(2003)241 cited
- → Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes ( REWIND ) trial on the cardiovascular effects of dulaglutide(2017)184 cited
- → Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies(2010)158 cited
- → Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes(2002)156 cited
- → Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.(1999)149 cited